Patron Partners LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 9,663 shares of the company’s stock, valued at approximately $1,242,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Frazier Financial Advisors LLC purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $25,000. Kilter Group LLC bought a new position in shares of Merck KGaA during the second quarter valued at approximately $62,000. Addison Advisors LLC purchased a new stake in Merck KGaA in the second quarter worth $90,000. Hara Capital LLC purchased a new stake in Merck KGaA in the second quarter worth $110,000. Finally, Comprehensive Financial Planning Inc. PA bought a new stake in Merck KGaA in the second quarter valued at $134,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.7%
Shares of OTCMKTS MKGAF opened at $163.21 on Friday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The firm has a market capitalization of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. The firm has a fifty day simple moving average of $162.62 and a two-hundred day simple moving average of $148.46.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
